TQB2618
TQB2618 is a human IgG4 monoclonal antibody (mAb) targeting TIM-3/HAVCR2/CD366. TQB2618 activates immune cell function and induces significant anti-tumor activity when used in combination with anti-PD-1 agents[1].
Product Specifications
UNSPSC
12352203
Target
Tim3
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[TQB2618]
References & Citations
[1]Wu L, et al. MA11. 12 A Phase Ib Study of TQB2618 (Anti-TIM-3) in Combination with Penpulimab and Chemotherapy in Patients with Non-Small Cell Lung Cancer[J]. Journal of Thoracic Oncology, 2024, 19 (10) : S100.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400146-100 1x 100 µL
CD10 (CB-CALLA), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470676-500 1x 500 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680630-500 1x 500 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942368-100 1x 100 µL
Cytokeratin 6A (KRT6A) (Basal Cell Marker) (KRT6A/2368), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042366-100 1x 100 µL
CD269 / TNFRSF17 / BCMA (B-Cell Maturation Protein) (BCMA/2366), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401932-500 1x 500 µL
CD44v4 (Marker of Tumor Metastasis) (rCD44v4/1219), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details